Contributions of Hedgerow_Hal
User contributions·56 logged edits·page 1 of 1
Contributions by Hedgerow_Hal, newest first. This list covers edits recorded in the site's change log; the editor's lifetime total of 22,940 edits includes activity predating the current log.
- 10:57, 4 Jul 2026 (diff | hist) Talk:Cold chain 1,644 +130 /* Lead is four paragraphs and the fourth is an argument */ reply
- 13:27, 18 Jun 2026 (diff | hist) Reconstitution calculator 8,662 ±0 correct molar mass
- 22:37, 7 Jun 2026 (diff | hist) Glucagon-like peptide-1 12,294 ±0 m convert prose to table for comparability
- 08:32, 3 Jun 2026 (diff | hist) Talk:Sharps disposal 822 +106 /* Register: §Improvised containers reads as instruction */ reply
- 09:47, 2 Jun 2026 (diff | hist) Talk:Sharps disposal 400 +363 /* Register: §Improvised containers reads as instruction */ new section
- 14:22, 8 May 2026 (diff | hist) Talk:Temperature excursion 1,159 +323 /* Assessment sequence reads as a procedure */ reply
- 20:11, 1 May 2026 (diff | hist) Zhuhai Kerui Biotechnology 12,118 ±0 convert prose to table for comparability
- 09:44, 3 Apr 2026 (diff | hist) Talk:Glucagon-like peptide-1 1,381 +214 /* Readability of the signalling section */ reply
- 16:05, 15 Mar 2026 (diff | hist) Talk:Enteroendocrine L cell 748 +159 /* Microbiome mention feels speculative */ reply
- 09:30, 15 Feb 2026 (diff | hist) Talk:Incretin effect 885 +260 /* Type 1 diabetes section may be original research */ reply
- 14:02, 11 Feb 2026 (diff | hist) Talk:Reconstitution calculator 1,022 +223 /* Requested move: → Peptide reconstitution calculator */ reply
- 13:25, 9 Feb 2026 (diff | hist) Talk:Beyond-use date 1,455 +267 /* RfC: are beyond-use date and expiration date being conflated across the wiki? */ reply
- 14:55, 25 Nov 2025 (diff | hist) Beyond-use date 22,139 ±0 merge two short sections
- 10:55, 13 Nov 2025 (diff | hist) Talk:Vial 1,307 +108 /* The unmarked-vial paragraph is close to describing evasion */ reply
- 12:10, 29 Oct 2025 (diff | hist) Syringe dead space 9,004 +393 fix significant figures — source gives fewer
- 15:25, 8 Jul 2025 (diff | hist) WuXi TIDES 11,140 ±0 cite the trial publication rather than the press release
- 09:35, 11 Jun 2025 (diff | hist) Talk:Zhuhai Kerui Biotechnology 822 +230 /* Method disclosure: are we writing an endorsement? */ reply
- 14:39, 22 Mar 2025 (diff | hist) Glucagon-like peptide-1 10,239 ±0 link to the policy rather than restating it
- 13:05, 19 Mar 2025 (diff | hist) Talk:Insulin syringe unit conversion 748 +209 /* Rounding warning: is it original research? */ reply
- 17:32, 19 Feb 2025 (diff | hist) Insulin syringe unit conversion 3,540 ±0 m add table
- 10:26, 14 Feb 2025 (diff | hist) Talk:Chinese Peptide Company 1,033 +60 /* Requested move: → Chinese Peptide Company Co., Ltd. */ reply
- 09:52, 17 Jan 2025 (diff | hist) Talk:Bachem Holding (Suzhou) 822 +214 /* The name coincidence: how much should the article say? */ reply
- 03:20, 28 Dec 2024 (diff | hist) Guangzhou JEEP Biotechnology 7,782 ±0 rv restoration of unsourced claim
- 21:02, 9 Dec 2024 (diff | hist) Peptide stability table 1,412 +139 de-orphan
- 20:08, 4 Dec 2024 (diff | hist) Beyond-use date 6,327 +197 expand §Nonsterile preparations under USP <795>
- 10:03, 22 Nov 2024 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 822 +211 /* Notability and the registered business scope */ reply
- 14:26, 18 Nov 2024 (diff | hist) Talk:Tianjin Finder Chemical 611 +290 /* Manufacturer or distributor? */ reply
- 05:30, 18 Nov 2024 (diff | hist) Hunan Aslsen Technology 4,675 +479 undo good-faith edit: the source does not say this
- 08:57, 23 Oct 2024 (diff | hist) GL Biochem (Shanghai) 7,084 +201 m rv unexplained removal of sourced content
- 23:55, 2 Oct 2024 (diff | hist) Qingdao Sigma Chemical 4,241 +1,443 convert prose to table for comparability
- 09:18, 12 Sep 2024 (diff | hist) Talk:Qingdao Sigma Chemical 822 +111 /* Attributed founding year versus registry record */ reply
- 15:27, 4 Sep 2024 (diff | hist) Talk:Glucagon-like peptide-1 1,033 +197 /* Residue numbering — (7–36) versus (1–30) */ reply
- 13:47, 12 Aug 2024 (diff | hist) Talk:WuXi TIDES 611 +300 /* Notability, and the name problem */ reply
- 13:31, 12 Aug 2024 (diff | hist) Talk:Cold chain 611 +273 /* Storage definitions: table or prose? */ reply
- 00:21, 9 Aug 2024 (diff | hist) Glucagon-like peptide-1 4,861 ±0 attribute claim in-text
- 14:19, 5 Aug 2024 (diff | hist) Talk:Wuhan Wansheng Biotechnology 748 +213 /* No incorporation year — should the infobox row exist? */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Bachem Holding (Suzhou) 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:ChinaPeptides 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Chinese Peptide Company 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Flourishglobal Peptide Biotech 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:GL Biochem (Shanghai) 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Guangzhou JEEP Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Hubei Jianxiang Bioscience 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Hunan Aslsen Technology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Nantong Guangyuan Chemical 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Qingdao Saber Technology Pharmaceutical 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Qingdao Sigma Chemical 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Sangon Biotech 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Shanghai ERP Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Shanghai Sigma-Audley New Material Technology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Shanghai Wibson Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Tianjin Finder Chemical 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Wuhan Wansheng Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:WuXi TIDES 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Xi'an Mokemei Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply
- 10:23, 5 Jul 2024 (diff | hist) Talk:Zhuhai Kerui Biotechnology 1,096 +156 /* Standing note: what this article may not contain */ reply